-
Steve Saviuk, CEO of Valeo Pharma, Discusses Promising Results of COVID-19 Drug Sabizabulin and Revenue Growth in 2023
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO, and…
-
F3 Uranium’s CEO Dev Randhawa on Rising Uranium Demand and Recent High-Grade Hits at its PLN Property
In this InvestorIntel interview, Tracy Weslosky talks to F3 Uranium Corp.‘s (TSXV: FUU | OTCQB: FUUFF) CEO and…
-
Zentek’s ZenARMOR is potentially a major breakthrough in the US$23.8B+ Global Anti-Corrosion Coatings Market
The anti-corrosion coatings market may not sound very glamorous, but it is a multi-billion dollar business. According to…
-
Valeo Pharma’s CEO Steve Saviuk Talks about Record FQ4 & F2022 Revenue Up 274% & 105%, Respectively
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO,…
-
Greg Fenton on ZenARMOR, Zentek’s novel corrosion protection technology
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
Greg Fenton on the impact of Zentek’s HVAC Phase 2 Testing results on Air Filtration
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director…
